5-(2-Methoxyethoxy)pyridine-2-carboxylic acid, 250mg

ETHYL 8-CHLORO[1,3]DIOXOLO[4,5-G]QUINOLINE-7-CARBOXYLATE, 95.0%, 5g

(S)-Benzyl 2-(8-amino-1-bromoimidazo[1,5-a]pyrazin-3-yl)pyrrolidine-1-carboxylate, 97.0%, 1g

(3-Chloro-phenyl)-methanesulfonyl chloride, 95.0%, 5g

1,4-Cyclohexadiene ~0.1% hydroquinone as stabilizer, 5g

1H-Imidazo[4,5-c]pyridine-2(3H)-thione, 95.0%, 1g

3'-Azido-2'3'-ddCTP, ≥95 %, 500 µl, kunststoffverpackung.

1-(Cyclobutylmethyl)-2-oxo-1,2-dihydropyrimidine-5-carboxylic acid, 1g

4-methylenepiperidine hydrobromide, 100mg

2-(Difluoromethoxy)benzaldehyde, 96.0%, 1g

TERT-BUTYL (3AR,4S,6AS)-4-AMINO-OCTAHYDROCYCLOPENTA[C]PYRROLE-2-CARBOXYLATE, 95.0%, 1g

Methyl (4-chloro-3-trifluoromethylphenyl)carbamate, 2g

TERT-BUTYL 2-AMINO-4-FORMYLTHIAZOLE-3(2H)-CARBOXYLATE, 95%, 5g